Reversal of corticosteroid-induced diabetes mellitus with supplemental chromium

Diabet Med. 1999 Feb;16(2):164-7. doi: 10.1046/j.1464-5491.1999.00004.x.


Aims: To determine if the stress of corticosteroid treatment increases chromium (Cr) losses and if corticosteroid-induced diabetes (steroid diabetes) can be reversed by supplemental chromium.

Methods: The effects of corticosteroid treatment on chromium losses of 13 patients 2 days prior to steroid administration and the first 3 days following treatment were determined. Since steroid-induced diabetes was associated with increased chromium losses and insufficient dietary chromium is associated with glucose intolerance and diabetes, we treated three patients with steroid-induced diabetes with 600 microg per day of chromium as chromium picolinate.

Results: Urinary chromium losses following corticosteroid treatment increased from 155+/-28 ng/d before corticosteroid treatment to 244+/-33 ng/d in the first 3 days following treatment. Chromium supplementation of patients with steroid-induced diabetes resulted in decreases in fasting blood glucose values from greater than 13.9 mmol/l (250 mg/dl) to less than 8.3 mmol/l (150 mg/dl). Hypoglycaemic drugs were also reduced 50% in all patients when given supplemental chromium.

Conclusions: These data demonstrate that corticosteroid treatment increases chromium losses and that steroid-induced diabetes can be reversed by chromium supplementation. Follow-up, double-blind studies are needed to confirm these observations.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenal Cortex Hormones / adverse effects*
  • Adult
  • Chromium / deficiency
  • Chromium / therapeutic use*
  • Chromium / urine
  • Diabetes Mellitus / chemically induced*
  • Diabetes Mellitus / physiopathology
  • Diabetes Mellitus / urine
  • Dietary Supplements*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pilot Projects


  • Adrenal Cortex Hormones
  • Chromium